Top Companies in the Clinical Trial Software Market
- Medidata (a Dassault Systèmes company)
- Veeva Systems
- Oracle Health / Oracle Clinical (InForm historically)
- IQVIA
- Parexel Informatics / Perceptive (Parexel)
- Medable
- Signant Health
- Clario
- OmniComm Systems
- Castor EDC
- Medrio
- Viedoc
- ArisGlobal
- OpenClinica
- eClinical Solutions
Market Forecast
The global clinical trial software market size in 2024 was US$ 0.9 billion, expected to grow to US$ 1.03 billion in 2025 and further to US$ 3.23 billion by 2034, backed by a robust CAGR of 13.74% between 2025 and 2034.
What are the Key trends in the Clinical Trial Software Market in 2024?
Market Consolidation: Mergers help companies expand their market presence and reduce competition by uniting complementary strengths.
- In March 2024, Thermo Fisher Scientific partnered with Oracle Health Sciences to link its clinical trial supply services with the CTMS platform of Oracle. The collaboration is designed to simplify trial operations and enhance data flow between supply chain management and trial oversight systems.
Integration of Emerging Technologies: Companies are launching platforms with AI, blockchain, and cloud capabilities to improve data accuracy, security, and scalability.
- In January 2024, BSI Life Sciences revealed Ocular Therapeutix as a new client for its cloud-based Clinical Trial Management System, expanding the adoption in managing clinical research efficiently of the software.
Latest Announcement by Industry Leaders
In June 2024, IQVIA launched One Home for Sites™, a new platform designed to simplify operations for clinical research sites. The platform provides a single sign-on and unified dashboard, integrating multiple software applications used in trials, reducing the time staff spend managing logins and navigating systems. This allows sites to focus more on patient care and trial management. Bernd Haas, Senior VP of IQVIA, stated that the platform addresses technology overload and helps maximize site capacity by connecting all stakeholders efficiently.
Recent Developments in the Clinical Trial Software Market
- In May 2025, Medidata Solutions, part of Dassault Systèmes, received a USD 150 million investment led by BlackRock. The funding aims to drive the growth of the company in the CTMS market and support the development of advanced technologies to improve clinical trial efficiency and streamline trial management processes.
- In June 2024, Lokavant, a U.S.-based clinical trial software company, launched Spectrum, an AI-powered feasibility platform designed to optimize clinical trials. The solution enhances trial management across the entire lifecycle, supporting activities from initial planning to mid-study re-forecasting, thereby improving efficiency and decision-making throughout the study process.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
